Progressive multifocal leukoencephalopathy in the era of new disease-modifying treatments for multiple sclerosis

被引：0
|
作者：
Filippi-Arriaga, Francesca [1 ]
Riera-Arnau, Judit [1 ]
Rodriguez-Acevedo, Breogan [2 ]
Bosch Ferrer, Montserrat [1 ]
机构：
[1] Univ Autonoma Barcelona, Serv Farmacol Clin, Hosp Univ Vall Hebron, Barcelona, Spain
[2] Univ Autonoma Barcelona, Unitat Neuroinmunol Clin, Ctr Esderosi Multiple Catalunya Cemcat,Serv Neuro, Vall Hebron Inst Recerca VHIR,Hosp Univ Vall Hebr, Barcelona, Spain
来源：
MEDICINA CLINICA | 2021年 / 156卷 / 10期
关键词：
PML;
D O I：
10.1016/j.medcli.2020.10.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：509 / 514
页数：6
相关论文
共 50 条
  • [1] Progressive Multifocal Leukoencephalopathy as a Complication of Disease-modifying Treatment of Multiple Sclerosis
    M. N. Zakharova
    E. V. Lysogorskaia
    M. V. Ivanova
    I. A. Kochergin
    Y. E. Korzhova
    [J]. Human Physiology, 2019, 45 (8) : 863 - 868
  • [2] Disease-modifying treatments for progressive multiple sclerosis
    Comi, Giancarlo
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1428 - 1436
  • [3] Cancer and multiple sclerosis in the era of disease-modifying treatments
    Lebrun, Christine
    Vermersch, Patrick
    Brassat, David
    Defer, Gilles
    Rumbach, Lucien
    Clavelou, Pierre
    Debouverie, Marc
    de Seze, Jerome
    Wiertlevsky, Sandrine
    Heinzlef, Olivier
    Tourbah, Ayman
    Fromont, Agnes
    Frenay, Marc
    [J]. JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1304 - 1311
  • [4] Cancer and multiple sclerosis in the era of disease-modifying treatments
    Christine Lebrun
    Patrick Vermersch
    David Brassat
    Gilles Defer
    Lucien Rumbach
    Pierre Clavelou
    Marc Debouverie
    Jérôme de Seze
    Sandrine Wiertlevsky
    Olivier Heinzlef
    Ayman Tourbah
    Agnes Fromont
    Marc Frenay
    [J]. Journal of Neurology, 2011, 258 : 1304 - 1311
  • [5] Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis
    Sriwastava, Shitiz
    Kataria, Saurabh
    Srivastava, Samiksha
    Kazemlou, Shaghayegh
    Gao, Si
    Wen, Sijin
    Saber, Hamidreza
    Tripathi, Richa
    Sheikh, Zubeda
    Peterson, Sarah
    Gwinn, Ronald
    Bernitsas, Evanthia
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [6] Choosing Disease-Modifying Therapy in Multiple Sclerosis (MS) Patients with Progressive Multifocal Leukoencephalopathy (PML): Now What?
    Anadani, Nidhiben
    Samkoff, Lawrence
    Hyland, Megan
    Robb, Jessica
    Goodman, Andrew D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 43 - 43
  • [7] The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis
    Brown, J. W. L.
    Coles, A.
    Horakova, D.
    Havrdova, E.
    Trojano, M.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Hupperts, R.
    Van Pesch, V.
    Ferraro, D.
    Alroughani, R.
    Bergamaschi, R.
    Pucci, E.
    Iuliano, G.
    Lechner-Scott, J.
    Spelman, T.
    Jokubaitis, V.
    Ramo-Tello, C.
    Spitaleri, D.
    Granella, F.
    Solaro, C.
    Ampapa, R.
    Deri, N.
    McCombe, P.
    Petersen, T.
    Van Wijmeersch, B.
    Prevost, J.
    Sanchez-Menoyo, J. L.
    Soysal, A.
    Barnett, M.
    Moore, F.
    Rice, C.
    Scolding, N.
    Wilkins, A.
    McGuigan, C.
    Hutchinson, M.
    Ziemssen, T.
    Pearson, O.
    Harding, K.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Terzi, M.
    Shaygannejad, V.
    Sola, P.
    Butzkueven, H.
    Kalincik, T.
    Robsertson, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 32 - 34
  • [8] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
  • [9] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    [J]. Current Treatment Options in Neurology, 2018, 20
  • [10] Update on Disease-Modifying Treatments for Multiple Sclerosis
    Carrithers, Michael D.
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (12) : 1938 - 1945
12345